This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified medical devices associated with adverse incidents
VWXY20_OTHER_UNSPE_MEDICAL_DEVICES_ASSOCIATED_W_ADVER_INCIDENTS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
168 |
4. Check minimum number of eventsNone |
168 |
5. Include endpointsNone |
168 |
6. Filter based on genotype QC (FinnGen only) |
168 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y7|Y8[0-2]
Similar endpoints
↥List of similar endpoints to
Other and unspecified medical devices associated with adverse incidents
based on the number of shared cases.
Similar with more cases:
- therapeutic use
- Complications of medical and surgical care
- External causes of morbidity and mortality
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 168 | 87 | 81 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 66.68 | 65.47 | 67.97 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 148
- Matched controls
- 1482
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y82.3
ICD-10 Finland
Other and unspecified medical devices associated with adverse incidents, surgical instruments, materials and devices (including sutures)
+∞
82.1
71
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
58.6
62.7
73
24
Y82
ICD-10 Finland
Other and unspecified medical devices associated with adverse incidents
+∞
41.6
38
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
112.2
39.1
41
5
NE1AA
NOMESCO Finland
Pelvis X-ray examination
17.3
36.8
62
59
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
16.5
32.5
55
51
R4110
NOMESCO Finland
Physiotherapy
8.6
31.9
97
268
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
32.6
29.8
39
16
M16.1
ICD-10 Finland
Other primary coxarthrosis
10.4
29.4
65
103
Y82.2
ICD-10 Finland
Other and unspecified medical devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices
+∞
25.8
24
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.6
23.9
50
68
WX320
NOMESCO Finland
Spinalanesthesy
6.4
22.5
74
199
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
31.0
21.4
28
11
B01AB05
ATC
enoxaparin; parenteral
5.5
21.0
90
325
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
56.8
20.9
24
5
WX002
NOMESCO Finland
Sedation and analgesia
5.4
18.8
72
221
NF1AA
NOMESCO Finland
Hip X-ray examination
8.2
17.7
42
68
ZXA05
NOMESCO Finland
Left side
4.8
17.6
79
283
N02AX02
ATC
tramadol; systemic, rectal
4.5
16.9
98
446
WX306
NOMESCO Finland
Lumbar epidural anesthesy
10.6
16.6
33
39
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.0
15.7
48
109
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
17.6
15.5
24
16
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
8.5
15.1
34
50
X59
ICD-10 Finland
Exposure to unspecified factor
4.9
14.7
57
169
ZXA00
NOMESCO Finland
Right side
4.1
14.4
79
323
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
59.3
14.1
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.6
14.0
34
56
Y82.8
ICD-10 Finland
Other and unspecified medical devices associated with adverse incidents, miscellaneous devices, not elsewhere classified
+∞
13.8
13
*
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
+∞
13.8
13
*
B01AX06
ATC
[U] rivaroxaban; oral
15.1
12.9
21
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.3
12.9
57
189
NFC00
NOMESCO Finland
Exchange of a loose part of prosthesis in hip joint
70.7
11.8
13
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.5
11.8
95
503
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
12.0
11.2
20
19
S73.0
ICD-10 Finland
Dislocation of hip
47.2
11.1
13
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.1
11.1
49
159
L13
ICPC
Hip symptom/complaint
4.3
10.8
44
132
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
64.8
10.8
12
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.4
10.1
39
111
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
14.8
9.9
16
12
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
106.6
9.5
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
9.0
66
306
XF400
NOMESCO Finland
ECG with 12 standard connections
3.7
9.0
44
153
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
8.7
41
138
WX111
NOMESCO Finland
Local infiltration anesthesia
11.8
8.5
15
14
J01MA02
ATC
ciprofloxacin; systemic
2.8
8.4
76
402
M79.6
ICD-10 Finland
Pain in limb
2.9
8.2
70
354
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
18.5
8.2
12
7
J04AB02
ATC
rifampicin; systemic
18.5
8.2
12
7
N02AA05
ATC
oxycodone; systemic
3.6
7.9
37
124
Z50.1
ICD-10 Finland
Other physical therapy
5.7
7.8
22
44
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.1
7.8
51
217
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
7.6
16
21
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.7
7.6
78
434
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
7.6
31
92
NG1AD
NOMESCO Finland
Knee CT examination
14.4
7.5
12
9
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.1
7.5
23
51
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.5
7.2
14
16
SAA03
NOMESCO Finland
Extended examination of mouth
2.6
7.2
70
376
J01FF01
ATC
clindamycin; systemic
2.7
7.1
59
288
WZA00
NOMESCO Finland
Short statement of of health and health related matters
5.6
7.1
20
40
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
7.1
84
504
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
17.7
6.8
10
6
N03AX16
ATC
pregabalin; oral
2.8
6.7
49
221
B01AB04
ATC
dalteparin; parenteral
5.2
6.7
20
43
WZA90
NOMESCO Finland
Other doctors statement
2.8
6.6
50
229
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
6.6
21
49
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.0
6.6
26
75
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
6.4
28
88
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
6.4
30
100
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.8
6.4
15
24
X58
ICD-10 Finland
Exposure to other specified factors
3.3
6.3
32
114
M03BC01
ATC
orphenadrine (citrate); systemic
2.9
6.2
41
174
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
6.0
57
294
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.9
6.0
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
52
34
21.70
62.47
3.1
1.5
—
—
—
0
0
33
33
12.20
30.16
1.8
1.5
37906.5
25421.6
e6/l
0.22
18
23
83
346
3.76
16.12
3.2
2.5
—
—
—
0
0
72
285
3.67
14.91
3.7
3.6
173.0
142.1
ng/l
0.12
63
235
69
273
3.59
14.19
3.4
2.9
1.0
1.0
e6/l
0.02
40
153
66
254
3.63
14.16
3.5
3.0
1.9
2.2
e6/l
0.13
36
136
44
132
4.16
13.46
7.8
7.4
1.5
1.4
mmol/l
0.20
44
126
93
456
3.33
13.33
5.5
3.2
0.8
0.5
e6/l
0.34
79
343
45
142
3.96
12.80
3.4
2.6
29.1
29.6
u/l
0.03
35
114
77
359
3.11
11.67
2.6
2.0
3.1
3.3
mg/l
0.29
66
312
113
667
3.12
11.02
5.3
4.1
—
—
—
0
0
21
40
5.86
10.90
2.5
1.5
—
—
—
0
0
104
622
2.76
9.28
2.5
1.9
86.7
92.5
pmol/l
0.74
53
309
94
550
2.61
8.53
5.7
3.4
—
—
—
0
0
42
164
3.08
8.32
2.1
1.8
—
—
—
0
0
43
172
3.02
8.16
4.5
3.2
7.1
8.9
umol/l
0.32
36
150
41
163
3.00
7.84
2.1
1.8
—
—
—
0
0
26
80
3.66
7.47
7.0
4.1
24.4
24.2
mmol/l
0.14
26
74
72
390
2.48
7.45
1.7
1.5
21.1
21.4
nmol/l
0.06
63
330
123
860
2.61
7.11
15.4
10.0
4.2
4.2
e9/l
0.07
104
751
45
199
2.72
7.02
9.7
7.1
103.8
103.5
mmol/l
0.11
45
194
29
102
3.23
6.77
2.6
1.6
—
—
—
0
0
110
752
2.34
6.36
13.3
6.6
1.2
1.2
mmol/l
0.57
104
638
24
79
3.38
6.21
1.6
1.8
—
—
—
0
0
39
170
2.69
6.20
9.2
7.6
0.1
1.1
mmol/l
1.14
29
141
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
45
4.09
5.98
3.8
2.2
0.2
0.4
u/ml
—
7
22
92
594
2.21
5.97
4.4
2.6
160.4
133.4
ug/l
0.39
85
542
47
232
2.42
5.75
2.2
1.9
—
—
—
0
0
20
64
3.41
5.39
1.2
1.8
—
—
—
0
0
5
0
+∞
5.23
2.2
0.0
3.4
—
umol/l
—
5
0
80
508
2.10
5.22
3.1
3.3
2.4
2.4
mmol/l
0.24
70
445
150
1231
3.04
5.09
42.2
16.1
37.6
39.8
%
2.66
128
875
17
51
3.60
5.04
1.2
1.2
—
—
—
0
0
160
1399
4.02
5.00
35.3
15.8
30.4
23.3
mg/l
1.90
143
1108
17
52
3.52
4.90
1.2
1.2
—
—
—
0
0
14
39
3.83
4.59
1.4
1.2
—
—
—
0
0
12
30
4.23
4.52
1.3
1.3
—
—
—
0
0
12
30
4.23
4.52
1.3
1.3
—
—
—
0
0
87
592
1.97
4.49
2.9
2.3
78.8
77.8
nmol/l
0.12
77
518
97
691
1.96
4.32
12.6
5.9
1.2
1.2
mmol/l
1.04
92
630
51
290
2.09
4.32
3.6
3.1
2.5
2.5
mmol/l
0.33
40
256
19
72
2.85
3.88
1.3
1.3
—
—
—
0
0
113
874
1.89
3.66
7.7
4.9
6.9
6.8
mmol/l
0.32
107
818
53
323
1.94
3.64
2.3
1.8
1.2
1.4
mg/l
0.43
46
259
13
41
3.35
3.58
2.4
1.5
—
—
—
0
0
12
36
3.51
3.55
1.8
1.1
—
—
—
0
0
22
96
2.49
3.44
1.4
1.4
—
—
—
0
0
61
396
1.85
3.42
1.7
1.6
1.4
1.3
mmol/l
0.22
55
329
26
125
2.28
3.30
7.0
2.9
5.0
4.2
kpa
1.02
26
120
152
1333
2.47
3.11
29.5
15.4
80.1
77.6
ml/min/173m2
0.77
142
1088
101
784
1.72
2.93
2.8
2.7
—
—
—
0
0
12
42
3.00
2.81
3.1
2.5
202.1
200.8
%
0.02
12
42
6
10
6.17
2.72
1.0
1.0
—
—
—
0
0
6
10
6.17
2.72
1.0
1.0
—
—
—
0
0
160
1471
2.84
2.64
39.3
18.0
138.5
139.6
mmol/l
4.45
160
1433
6
11
5.61
2.56
1.3
1.7
—
—
—
0
0
160
1477
2.75
2.50
40.4
18.1
4.0
4.0
mmol/l
0.22
160
1438
10
34
3.06
2.45
2.2
1.2
—
—
—
0
0
55
389
1.62
2.13
2.5
2.9
348.8
4992.8
umol/l
1.49
48
336
16
76
2.22
2.10
3.1
2.6
0.9
1.2
%
0.86
16
76
47
323
1.63
2.03
3.1
3.0
0.6
0.8
ug/l
0.80
35
226
21
114
1.96
1.98
10.2
3.8
137.6
81.5
ng/l
1.04
21
101
32
201
1.73
1.92
1.8
1.5
—
—
—
0
0
27
162
1.79
1.89
4.3
3.8
—
—
—
0
0
5
12
4.26
1.83
1.0
1.1
325.2
224.4
u/l
—
5
12
6
18
3.42
1.76
1.3
1.2
—
—
—
0
0
9
184
0.46
1.63
14.0
8.1
—
—
—
0
0
5
15
3.40
1.53
1.4
1.3
—
—
—
0
0
10
45
2.30
1.49
1.1
1.6
—
—
—
0
0
10
45
2.30
1.49
2.5
1.2
—
—
—
0
0
32
220
1.56
1.37
1.3
1.3
8.6
14.4
u/ml
—
9
81
145
1337
1.62
1.33
7.1
6.2
39.5
40.5
mmol/mol
0.63
138
1239
9
43
2.15
1.32
1.2
4.8
44.0
199.4
mg/l
—
9
34
9
43
2.15
1.32
1.2
4.8
34.4
32.6
mg/l
—
9
34
28
398
0.64
1.31
9.3
4.4
0.0
0.0
estimate
—
10
145
33
233
1.52
1.26
1.4
1.3
39.4
40.3
iu/ml
—
6
76
102
887
1.38
1.22
3.8
3.0
61.7
50.3
u/l
0.73
94
829
6
26
2.35
1.19
3.2
1.5
—
—
—
0
0
5
21
2.42
1.10
1.0
1.2
—
—
—
0
0
41
312
1.42
1.08
1.7
1.2
0.5
1.0
u/ml
—
6
78
147
1375
1.55
1.08
4.7
4.8
6.3
6.0
mmol/l
1.00
137
1247
140
1299
1.47
1.04
5.0
4.7
1.8
1.9
mu/l
1.26
131
1159
5
22
2.31
1.04
3.4
4.3
—
—
—
0
0
19
124
1.60
1.02
5.6
3.0
57.9
59.0
ml/min/173m2
—
7
54
116
1048
1.35
0.98
3.6
4.0
14.4
15.0
pmol/l
1.60
107
930
84
726
1.31
0.97
5.7
3.9
0.0
0.0
estimate
0.00
12
140
59
485
1.33
0.97
3.4
3.2
1278.9
1174.9
ng/l
0.12
49
400
9
51
1.81
0.96
3.6
3.1
—
—
—
0
0
149
1405
1.53
0.96
5.5
5.4
2.6
2.7
mmol/l
0.51
138
1275
83
718
1.31
0.94
7.8
5.2
0.0
0.0
estimate
0.00
11
149
54
441
1.33
0.92
4.3
4.6
25.0
20.9
%
0.81
22
234
82
712
1.30
0.89
5.7
4.0
0.0
0.0
estimate
0.00
12
151
6
30
2.04
0.88
3.3
1.8
—
—
—
0
0
13
81
1.66
0.84
2.1
1.4
—
—
—
0
0
6
33
1.85
0.80
1.0
1.1
—
—
—
0
0
46
547
0.78
0.70
7.0
4.2
—
—
—
0
0
13
87
1.54
0.65
2.2
1.5
—
—
—
0
0
9
139
0.63
0.63
17.0
4.3
1.2
1.2
mmol/l
—
9
123
143
1362
1.34
0.63
4.5
4.7
1.4
1.5
mmol/l
0.83
134
1230
5
30
1.69
0.62
1.4
1.5
—
—
—
0
0
0
20
0.00
0.61
0.0
1.8
—
—
—
0
0
0
21
0.00
0.60
0.0
2.3
—
21.0
—
0
8
143
1371
1.29
0.51
4.7
4.8
4.4
4.5
mmol/l
0.97
137
1252
6
92
0.64
0.43
1.2
1.7
—
—
—
0
0
6
94
0.63
0.43
12.7
3.7
5.2
5.1
kpa
—
6
84
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
9
71
1.28
0.37
1.1
1.0
—
—
—
0
0
6
43
1.41
0.35
4.3
1.7
—
—
—
0
0
9
76
1.19
0.25
2.2
3.4
0.4
0.1
e6/l
—
9
76
13
158
0.81
0.25
1.1
1.3
—
—
—
0
0
9
77
1.18
0.25
6.4
3.3
48.3
2032.6
u/ml
—
9
63
33
298
1.13
0.21
1.7
1.7
810.4
1280.0
nmol/l
3.22
27
230
0
11
0.00
0.21
0.0
4.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
33.2
—
0
12
136
1327
1.13
0.21
4.0
4.2
1.3
1.3
mmol/l
0.39
125
1192
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
50
1.21
0.20
2.3
2.2
—
—
—
0
0
5
45
1.11
0.10
4.8
1.6
—
—
—
0
0
5
47
1.07
0.09
2.4
1.8
—
—
—
0
0
59
607
0.96
0.07
3.7
4.2
24.9
42.0
ng/l
1.40
42
447
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
9
98
0.91
0.00
2.9
2.0
13.1
13.0
nmol/l
—
9
88
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
16.0
—
0
6
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
10.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
14.3
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_OTHER_UNSPE_MEDICAL_DEVICES_ASSOCIATED_W_ADVER_INCIDENTS – Other and unspecified medical devices associated with adverse incidents
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).